[cite web | title = Entrez Gene: LRIG1 leucine-rich repeats and immunoglobulin-like domains 1| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=26018| accessdate = ] ] PBB_Summary
section_title =
summary_text =
References
Further reading
PBB_Further_reading
citations =
*cite journal | author=Suzuki Y, Sato N, Tohyama M, "et al." |title=cDNA cloning of a novel membrane glycoprotein that is expressed specifically in glial cells in the mouse brain. LIG-1, a protein with leucine-rich repeats and immunoglobulin-like domains. |journal=J. Biol. Chem. |volume=271 |issue= 37 |pages= 22522–7 |year= 1996 |pmid= 8798419 |doi=
*cite journal | author=Nilsson J, Vallbo C, Guo D, "et al." |title=Cloning, characterization, and expression of human LIG1. |journal=Biochem. Biophys. Res. Commun. |volume=284 |issue= 5 |pages= 1155–61 |year= 2001 |pmid= 11414704 |doi= 10.1006/bbrc.2001.5092
*cite journal | author=Suzuki Y, Miura H, Tanemura A, "et al." |title=Targeted disruption of LIG-1 gene results in psoriasiform epidermal hyperplasia. |journal=FEBS Lett. |volume=521 |issue= 1-3 |pages= 67–71 |year= 2002 |pmid= 12067728 |doi=
*cite journal | author=Hedman H, Nilsson J, Guo D, Henriksson R |title=Is LRIG1 a tumour suppressor gene at chromosome 3p14.3? |journal=Acta oncologica (Stockholm, Sweden) |volume=41 |issue= 4 |pages= 352–4 |year= 2002 |pmid= 12234026 |doi=
*cite journal | author=Strausberg RL, Feingold EA, Grouse LH, "et al." |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899
*cite journal | author=Nilsson J, Starefeldt A, Henriksson R, Hedman H |title=LRIG1 protein in human cells and tissues. |journal=Cell Tissue Res. |volume=312 |issue= 1 |pages= 65–71 |year= 2004 |pmid= 12684867 |doi= 10.1007/s00441-003-0697-1
*cite journal | author=Thomasson M, Hedman H, Guo D, "et al." |title=LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT--PCR and immunohistochemical analysis. |journal=Br. J. Cancer |volume=89 |issue= 7 |pages= 1285–9 |year= 2003 |pmid= 14520461 |doi= 10.1038/sj.bjc.6601208
*cite journal | author=Gur G, Rubin C, Katz M, "et al." |title=LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. |journal=EMBO J. |volume=23 |issue= 16 |pages= 3270–81 |year= 2005 |pmid= 15282549 |doi= 10.1038/sj.emboj.7600342
*cite journal | author=Laederich MB, Funes-Duran M, Yen L, "et al." |title=The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. |journal=J. Biol. Chem. |volume=279 |issue= 45 |pages= 47050–6 |year= 2004 |pmid= 15345710 |doi= 10.1074/jbc.M409703200
*cite journal | author=Gerhard DS, Wagner L, Feingold EA, "et al." |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504
*cite journal | author=Ljuslinder I, Malmer B, Golovleva I, "et al." |title=Increased copy number at 3p14 in breast cancer. |journal=Breast Cancer Res. |volume=7 |issue= 5 |pages= R719–27 |year= 2006 |pmid= 16168117 |doi= 10.1186/bcr1279
*cite journal | author=Jensen KB, Watt FM |title=Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=103 |issue= 32 |pages= 11958–63 |year= 2006 |pmid= 16877544 |doi= 10.1073/pnas.0601886103
*cite journal | author=Shattuck DL, Miller JK, Laederich M, "et al." |title=LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy. |journal=Mol. Cell. Biol. |volume=27 |issue= 5 |pages= 1934–46 |year= 2007 |pmid= 17178829 |doi= 10.1128/MCB.00757-06
PBB_Controls
update_page = yes
require_manual_inspection = no
update_protein_box = yes
update_summary = yes
update_citations = yes
